ES266270A1 - Procedimiento para preparar vacunas poliomieliticas - Google Patents

Procedimiento para preparar vacunas poliomieliticas

Info

Publication number
ES266270A1
ES266270A1 ES0266270A ES266270A ES266270A1 ES 266270 A1 ES266270 A1 ES 266270A1 ES 0266270 A ES0266270 A ES 0266270A ES 266270 A ES266270 A ES 266270A ES 266270 A1 ES266270 A1 ES 266270A1
Authority
ES
Spain
Prior art keywords
benzyl alcohol
production
polio vaccines
alcohol stabilized
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0266270A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES266270A1 publication Critical patent/ES266270A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0016Combination vaccines based on diphtheria-tetanus-pertussis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32651Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES0266270A 1960-03-30 1961-03-22 Procedimiento para preparar vacunas poliomieliticas Expired ES266270A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18500A US3097142A (en) 1960-03-30 1960-03-30 Benzyl alcohol stabilized polio vaccines and production thereof

Publications (1)

Publication Number Publication Date
ES266270A1 true ES266270A1 (es) 1961-07-01

Family

ID=21788244

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0266270A Expired ES266270A1 (es) 1960-03-30 1961-03-22 Procedimiento para preparar vacunas poliomieliticas

Country Status (5)

Country Link
US (1) US3097142A (es)
BE (1) BE601851A (es)
ES (1) ES266270A1 (es)
FR (1) FR1265M (es)
GB (1) GB949400A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154900B (de) * 1961-10-10 1963-09-26 Behringwerke Ag Verfahren zur Herstellung einer Poliomyelitisvaccine
ATE163547T1 (de) * 1989-08-15 1998-03-15 Massachusetts Inst Technology Stabilisierte impfstoffzusammensetzungen
PE20100365A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR885966A (fr) * 1941-10-07 1943-09-30 Ig Farbenindustrie Ag Agents désinfectants
US2793160A (en) * 1955-05-09 1957-05-21 Parke Davis & Co Poliomyelitis vaccine

Also Published As

Publication number Publication date
FR1265M (fr) 1962-06-24
BE601851A (fr) 1961-09-27
US3097142A (en) 1963-07-09
GB949400A (en) 1964-02-12

Similar Documents

Publication Publication Date Title
GB1052537A (es)
GB960850A (en) Measles virus vaccine
ES266270A1 (es) Procedimiento para preparar vacunas poliomieliticas
BE591268A (fr) Vaccin anti-poliomyelitique.
ES446637A1 (es) Procedimiento para la preparacion de vacunas acelulares.
GB941119A (en) Improvements in or relating to fastening devices
ES266340A1 (es) Procedimiento para la preparaciën de vacunas poliemieliticas
DK104544C (da) Rodenticid og, fremgangsmåde til fremstilling af diphenyl-1',1'-acetyl-2-indandion-1,3-derivater til anvendelse i rodenticidet.
GB873008A (en) Improvements in or relating to break-back traps
GB956914A (en) Improvements in the production of n,o-dimethylhydroxylamine
GB558588A (en) Improvements in plant training or supporting devices
CA607992A (en) Stable poliomyelitis live virus vaccine
ES287531A1 (es) Procedimiento para la preparacion de una composicion insecticida o larvicida para usar contra los mosquitos
GB999705A (en) Improvements in or relating to crop guides
GB996926A (en) Improvements in or relating to tedders
GB888424A (en) 6-chloro-gramine and its preparation
GB770852A (en) Vaccine products and process of producing the same
ES224455A1 (es) PROCEDIMIENTO DE PREPARACIoN DE VACUNAS DE TROPISMO TISULAR
GB840050A (en) Improvements in or relating to magnetic amplifiers
GB864068A (en) Improvements in or relating to devices for laterally displacing crop lying on the ground
IE22524L (en) Poliomyelitis virus vaccine
FR11M (fr) Chlorhydrate de l'éther β-diéthylaminoéthylique de l'alcool dibromo-3,5 méthoxy-2 benzylique.
GB864262A (en) Manufacture of unsaturated aliphatic diols
ES255146A3 (es) Metodo de preparaciën de antigenos inmunizadores eficaces en la vacunaciën de ganado vacuno
GB617480A (en) Improvements connected with supports for plants and the like